Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025 and Dec 2025.
- Largest single sale: $17.5M (30,000 shares) of Thermo Fisher Scientific on Dec 2, 2025. Filing
- Last sale before this period: May 14, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| West Pharmaceutical Services (WST) | President and CEO, Director | Sep 10, 2026 | Sep 10, 2026 |
| Vertex Pharmaceuticals (VRTX) | Director | Oct 10, 2023 | May 5, 2026 |
| Thermo Fisher Scientific (TMO) | Executive Vice President | Aug 31, 2017 | Mar 2, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Feb 28, 2026, Thermo Fisher Scientific: 1,197 shares withheld by the company for taxes. 1 filing: 1
- Feb 25, 2026, Thermo Fisher Scientific: 2,231 shares awarded. 1 filing: 1
- Dec 4, 2025, Thermo Fisher Scientific: sold 22,046 shares for $12.4M, no plan disclosed; 40,683 shares acquired by exercising options. 1 filing: 1
- Dec 3, 2025, Thermo Fisher Scientific: sold 32,000 shares for $18.7M, no plan disclosed; 68,000 shares acquired by exercising options. 1 filing: 1
- Dec 2, 2025, Thermo Fisher Scientific: sold 30,000 shares for $17.5M, no plan disclosed; 36,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.